Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (512)	11/22/2001 8:07:54 PM
From: tuck	Read Replies (1) of 1005

Well, the partnership info is that Allos is looking for some. As is Medinox. Would they be looking for each other, or are they competing? There seems to be some overlap in the programs. ALTH owns all rights to all products, so you've got leverage there. Do you think it is OK that the PIII for brain cancer is enrolling so slowly? The company claims it is on track, and that it is "in Phase III," but enrollment is expected to go on for another year. Thank goodness they have fast track designation, is all I can say! Yahoo!'s cash figure of $54 million seems $4 million low. Q3 cash & equivalent given as $58 million in the 10Q. Seems like they'll have to finance before launching unless a partner helps. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next